ObvioHealth is excited to announce the completion of enrollment for its latest research engagement.
This virtual dermatology study will assess the impacts of a nutritional supplement on skin condition (hydration, smoothness and overall health) while gauging product satisfaction among participants.
The trial design for this study allows participants to enroll, complete activities, and communicate with the research team virtually. No site visits required. That translates to convenient participation for all involved:
EIC: Participants can review the electronic informed consent form (EIC) digitally, and at their own pace.
Open-Label: There will be no placebo, therefore, all participants will benefit from knowing that they are consuming the nutritional supplement.
Ship-to-Home: The study product ships directly to the subjects’ doorsteps. Upon study completion, participants are asked to simply discard the product.
Study Activities: Those enrolled will be asked to consume the supplement once-a-day for 12 weeks. Consumption will be recorded via e-diary. Questionnaires assessing skin type, satisfaction with study product, and changes to skin condition are to be completed periodically throughout.
Live Help Desk: Our research team is made available to answer questions via text or phone throughout the duration of the study.
Constant Reminders: Participants need not worry about marking their calendars for every deadline. Our digital app keeps them on-track, issuing reminders when necessary.
Safety: The safety and comfort of our participants is our top priority. Data regarding health-related changes will be analyzed for underlying potential concerns. The participant will be kept abreast of all findings.
Stress-Free Participants Provide Better Data
When participants are safe and happy, everyone wins.
Participants are crucial to data integrity, and better data leads to the availability of enhanced treatments for those who need them. We strive to ensure a convenient experience for our participants, and in turn, they contribute to the advancement of better solutions.
ObvioHealth is excited to announce the completion of enrollment for its latest research engagement.
This virtual dermatology study will assess the impacts of a nutritional supplement on skin condition (hydration, smoothness and overall health) while gauging product satisfaction among participants.
The trial design for this study allows participants to enroll, complete activities, and communicate with the research team virtually. No site visits required. That translates to convenient participation for all involved:
EIC: Participants can review the electronic informed consent form (EIC) digitally, and at their own pace.
Open-Label: There will be no placebo, therefore, all participants will benefit from knowing that they are consuming the nutritional supplement.
Ship-to-Home: The study product ships directly to the subjects’ doorsteps. Upon study completion, participants are asked to simply discard the product.
Study Activities: Those enrolled will be asked to consume the supplement once-a-day for 12 weeks. Consumption will be recorded via e-diary. Questionnaires assessing skin type, satisfaction with study product, and changes to skin condition are to be completed periodically throughout.
Live Help Desk: Our research team is made available to answer questions via text or phone throughout the duration of the study.
Constant Reminders: Participants need not worry about marking their calendars for every deadline. Our digital app keeps them on-track, issuing reminders when necessary.
Safety: The safety and comfort of our participants is our top priority. Data regarding health-related changes will be analyzed for underlying potential concerns. The participant will be kept abreast of all findings.
Stress-Free Participants Provide Better Data
When participants are safe and happy, everyone wins.
Participants are crucial to data integrity, and better data leads to the availability of enhanced treatments for those who need them. We strive to ensure a convenient experience for our participants, and in turn, they contribute to the advancement of better solutions.
ObvioHealth is excited to announce the completion of enrollment for its latest research engagement.
This virtual dermatology study will assess the impacts of a nutritional supplement on skin condition (hydration, smoothness and overall health) while gauging product satisfaction among participants.
The trial design for this study allows participants to enroll, complete activities, and communicate with the research team virtually. No site visits required. That translates to convenient participation for all involved:
EIC: Participants can review the electronic informed consent form (EIC) digitally, and at their own pace.
Open-Label: There will be no placebo, therefore, all participants will benefit from knowing that they are consuming the nutritional supplement.
Ship-to-Home: The study product ships directly to the subjects’ doorsteps. Upon study completion, participants are asked to simply discard the product.
Study Activities: Those enrolled will be asked to consume the supplement once-a-day for 12 weeks. Consumption will be recorded via e-diary. Questionnaires assessing skin type, satisfaction with study product, and changes to skin condition are to be completed periodically throughout.
Live Help Desk: Our research team is made available to answer questions via text or phone throughout the duration of the study.
Constant Reminders: Participants need not worry about marking their calendars for every deadline. Our digital app keeps them on-track, issuing reminders when necessary.
Safety: The safety and comfort of our participants is our top priority. Data regarding health-related changes will be analyzed for underlying potential concerns. The participant will be kept abreast of all findings.
Stress-Free Participants Provide Better Data
When participants are safe and happy, everyone wins.
Participants are crucial to data integrity, and better data leads to the availability of enhanced treatments for those who need them. We strive to ensure a convenient experience for our participants, and in turn, they contribute to the advancement of better solutions.
ObvioHealth is excited to announce the completion of enrollment for its latest research engagement.
This virtual dermatology study will assess the impacts of a nutritional supplement on skin condition (hydration, smoothness and overall health) while gauging product satisfaction among participants.
The trial design for this study allows participants to enroll, complete activities, and communicate with the research team virtually. No site visits required. That translates to convenient participation for all involved:
EIC: Participants can review the electronic informed consent form (EIC) digitally, and at their own pace.
Open-Label: There will be no placebo, therefore, all participants will benefit from knowing that they are consuming the nutritional supplement.
Ship-to-Home: The study product ships directly to the subjects’ doorsteps. Upon study completion, participants are asked to simply discard the product.
Study Activities: Those enrolled will be asked to consume the supplement once-a-day for 12 weeks. Consumption will be recorded via e-diary. Questionnaires assessing skin type, satisfaction with study product, and changes to skin condition are to be completed periodically throughout.
Live Help Desk: Our research team is made available to answer questions via text or phone throughout the duration of the study.
Constant Reminders: Participants need not worry about marking their calendars for every deadline. Our digital app keeps them on-track, issuing reminders when necessary.
Safety: The safety and comfort of our participants is our top priority. Data regarding health-related changes will be analyzed for underlying potential concerns. The participant will be kept abreast of all findings.
Stress-Free Participants Provide Better Data
When participants are safe and happy, everyone wins.
Participants are crucial to data integrity, and better data leads to the availability of enhanced treatments for those who need them. We strive to ensure a convenient experience for our participants, and in turn, they contribute to the advancement of better solutions.
ObvioHealth is excited to announce the completion of enrollment for its latest research engagement.
This virtual dermatology study will assess the impacts of a nutritional supplement on skin condition (hydration, smoothness and overall health) while gauging product satisfaction among participants.
The trial design for this study allows participants to enroll, complete activities, and communicate with the research team virtually. No site visits required. That translates to convenient participation for all involved:
EIC: Participants can review the electronic informed consent form (EIC) digitally, and at their own pace.
Open-Label: There will be no placebo, therefore, all participants will benefit from knowing that they are consuming the nutritional supplement.
Ship-to-Home: The study product ships directly to the subjects’ doorsteps. Upon study completion, participants are asked to simply discard the product.
Study Activities: Those enrolled will be asked to consume the supplement once-a-day for 12 weeks. Consumption will be recorded via e-diary. Questionnaires assessing skin type, satisfaction with study product, and changes to skin condition are to be completed periodically throughout.
Live Help Desk: Our research team is made available to answer questions via text or phone throughout the duration of the study.
Constant Reminders: Participants need not worry about marking their calendars for every deadline. Our digital app keeps them on-track, issuing reminders when necessary.
Safety: The safety and comfort of our participants is our top priority. Data regarding health-related changes will be analyzed for underlying potential concerns. The participant will be kept abreast of all findings.
Stress-Free Participants Provide Better Data
When participants are safe and happy, everyone wins.
Participants are crucial to data integrity, and better data leads to the availability of enhanced treatments for those who need them. We strive to ensure a convenient experience for our participants, and in turn, they contribute to the advancement of better solutions.
ObvioHealth is excited to announce the completion of enrollment for its latest research engagement.
This virtual dermatology study will assess the impacts of a nutritional supplement on skin condition (hydration, smoothness and overall health) while gauging product satisfaction among participants.
The trial design for this study allows participants to enroll, complete activities, and communicate with the research team virtually. No site visits required. That translates to convenient participation for all involved:
EIC: Participants can review the electronic informed consent form (EIC) digitally, and at their own pace.
Open-Label: There will be no placebo, therefore, all participants will benefit from knowing that they are consuming the nutritional supplement.
Ship-to-Home: The study product ships directly to the subjects’ doorsteps. Upon study completion, participants are asked to simply discard the product.
Study Activities: Those enrolled will be asked to consume the supplement once-a-day for 12 weeks. Consumption will be recorded via e-diary. Questionnaires assessing skin type, satisfaction with study product, and changes to skin condition are to be completed periodically throughout.
Live Help Desk: Our research team is made available to answer questions via text or phone throughout the duration of the study.
Constant Reminders: Participants need not worry about marking their calendars for every deadline. Our digital app keeps them on-track, issuing reminders when necessary.
Safety: The safety and comfort of our participants is our top priority. Data regarding health-related changes will be analyzed for underlying potential concerns. The participant will be kept abreast of all findings.
Stress-Free Participants Provide Better Data
When participants are safe and happy, everyone wins.
Participants are crucial to data integrity, and better data leads to the availability of enhanced treatments for those who need them. We strive to ensure a convenient experience for our participants, and in turn, they contribute to the advancement of better solutions.
ObvioHealth is excited to announce the completion of enrollment for its latest research engagement.
This virtual dermatology study will assess the impacts of a nutritional supplement on skin condition (hydration, smoothness and overall health) while gauging product satisfaction among participants.
The trial design for this study allows participants to enroll, complete activities, and communicate with the research team virtually. No site visits required. That translates to convenient participation for all involved:
EIC: Participants can review the electronic informed consent form (EIC) digitally, and at their own pace.
Open-Label: There will be no placebo, therefore, all participants will benefit from knowing that they are consuming the nutritional supplement.
Ship-to-Home: The study product ships directly to the subjects’ doorsteps. Upon study completion, participants are asked to simply discard the product.
Study Activities: Those enrolled will be asked to consume the supplement once-a-day for 12 weeks. Consumption will be recorded via e-diary. Questionnaires assessing skin type, satisfaction with study product, and changes to skin condition are to be completed periodically throughout.
Live Help Desk: Our research team is made available to answer questions via text or phone throughout the duration of the study.
Constant Reminders: Participants need not worry about marking their calendars for every deadline. Our digital app keeps them on-track, issuing reminders when necessary.
Safety: The safety and comfort of our participants is our top priority. Data regarding health-related changes will be analyzed for underlying potential concerns. The participant will be kept abreast of all findings.
Stress-Free Participants Provide Better Data
When participants are safe and happy, everyone wins.
Participants are crucial to data integrity, and better data leads to the availability of enhanced treatments for those who need them. We strive to ensure a convenient experience for our participants, and in turn, they contribute to the advancement of better solutions.
ObvioHealth recently completed the first-ever fully virtual urogynecology study to evaluate a medical digital intravaginal device for female stress urinary incontinence. In this randomized trial, pelvic floor muscle contractions were monitored.
ObvioHealth and Sterling IRB today announce a partnership to help speed access and adoption of decentralized clinical trials. The partnership makes Sterling IRB the preferred Institutional Review Board for ObvioHealth.
ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next generation DCT platform and app.